<scp> circEZH2 <sup>E2</sup> </scp> <sup> / <scp>E3</scp> </sup> is a dual suppressor of <scp>miR363</scp> / <scp>miR708</scp> to promote EZH2 expression and prostate cancer progression-Reference-Cited by-同舟云学术

circEZH2 ^E2 ^{/
E3} is a dual suppressor of miR363 / miR708 to promote EZH2 expression and prostate cancer progression

Published:2022-12-28 Issue:4 Volume:114 Page:1378-1395
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Su Zhengzheng¹,Zhang Mengni¹,Luo Han²,Zhong Jinjing¹,Tan Junya¹,Xu Yunyi¹,Pan Xiuyi¹,Zeng Hao³,Nie Ling¹,Xu Miao¹,Chen Ni¹,Chen Xueqin¹,Zhou Qiao¹^ORCID

Affiliation:

1. Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School Sichuan University Chengdu China

2. Department of Thyroid and Parathyroid Surgery West China Hospital of Sichuan University Chengdu China

3. Department of Urology, West China Hospital, West China Medical School Sichuan University Chengdu China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15694

Reference57 articles.

1. Prostate cancer

2. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer

3. The polycomb group protein EZH2 is involved in progression of prostate cancer

4. N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer

5. Down-regulation of Human DAB2IP Gene Expression Mediated by Polycomb Ezh2 Complex and Histone Deacetylase in Prostate Cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CircEZH2 promotes gallbladder cancer progression and lipid metabolism reprogramming through the miR-556-5p/SCD1 axis;iScience;2024-08

2. Cellular senescence: A potential mode of circular RNAs regulating prostate cancer;MedComm – Oncology;2023-12

3. A novel intronic circular RNA circFGFR1int2 up-regulates FGFR1 by recruiting transcriptional activators P65/FUS and suppressing miR-4687-5p to promote prostate cancer progression;Journal of Translational Medicine;2023-11-22